600594.SS Stock Analysis
60
Uncovered
Guizhou Yibai Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Guizhou Yibai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Guiyang, Guizhou and currently employs 6,161 full-time employees. The company went IPO on 2004-03-23. The firm provides prescription drugs and over the counter (OTC) products, including injections, capsules, oral liquid, granules and tablets, among others. The firm's products are applied in the treatment of cancer, cardiovascular and cerebrovascular, orthopedics, digestion, gynecology, children and breathing, among others. The firm mainly conducts its businesses within domestic markets.